lanreotide acetate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe
AUST R: 371881
Active ingredients:
lanreotide acetate

Dosage form:
Injection, solution

Sponsor:
Amdipharm Mercury Australia Pty Ltd

Phone:
1800 627 680

From
29 Nov 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
An alternative generic product is available.